Pharmacological evidence for the role of central alpha 1B-adrenoceptors in the motor activity and spontaneous movement of mice

Neuropharmacology

Volumn 40, Issue 2, 2001, Pages 254-261

  Stone, Eric A ^a   Lin, Yan ^a   Itteera, Annupriya ^a   Quartermain, David ^a  

^a NEW YORK UNIVERSITY   (United States)

Author keywords

Alpha 1B adrenoceptor; Antagonist affinity; Central noradrenergic system; Motor activity; Movement

Indexed keywords

2 [[2 (2,6 DIMETHOXYPHENOXY)ETHYL]AMINOMETHYL] 1,4 BENZODIOXAN; 5 METHYLURAPIDIL; 8 [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] 8 AZASPIRO[4.5]DECANE 7,9 DIONE; ALPHA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; ALPHA 1B ADRENERGIC RECEPTOR; ALPHA ADRENERGIC RECEPTOR; BENOXATHIAN; PHENTOLAMINE; RECEPTOR SUBTYPE; TERAZOSIN;

ADRENERGIC TRANSMISSION; ANIMAL EXPERIMENT; ARTICLE; BEHAVIOR; BINDING AFFINITY; BODY MOVEMENT; CONTROLLED STUDY; DOSE RESPONSE; HEAD MOVEMENT; MALE; MOTOR ACTIVITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; VIDEORECORDING;

ADRENERGIC ALPHA-ANTAGONISTS; ANIMALS; BRAIN; INJECTIONS, INTRAVENTRICULAR; MALE; MICE; MOTOR ACTIVITY; MOVEMENT; RECEPTORS, ADRENERGIC, ALPHA-1;

EID: 0035218155     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0028-3908(00)00151-9     Document Type: Article

References (46)

1. Localization of α(1B)-adrenergic receptor in female rat brain regions involved in stress and neuroendocrine function
2. R 28935 and prazosin: effects on central and peripheral alpha-adrenoceptor activity and on blood pressure
3. In vivo recetor occupancy of the angiotensin II receptor by nonpeptide antagonists: relationship to in vitro affinities and in vivo pharmacologic potency
4. Restraint-stress-induced changes in exploratory behavior appear to be mediated by norepinephrine-stimulated release of CRF
5. Locus coeruleus-induced modulation of forebrain electroencephalographic (EEG) state in halothane-anesthetized rat
6. 4,4-Dihydroxyphenylacetic acid (DOPAC) as an index of noradrenaline turnover: effects of hydergine and vincamine
7. Noradrenergic mechanisms in stress and anxiety. 1. Preclinical studies
8. Distribution of α(1a)-, α(1b)- and α(1d)-adrenergic receptor mRNA in the rat brain and spinal cord
9. CRF-induced excessive grooming behavior in rats and mice
10. Central alpha-1-adrenergic stimulation in relation to the behaviour stimulating effect of modafinil; studies with experimental animals
11. Expression of alpha 1-adrenoceptor subtypes in rat tissues: implications for alpha 1-adrenoceptor classification
12. The vigilance promoting drug modafinil increases dopamine release in the rat nucleus accumbens via the involvement of a local GABAergic mechanism
13. RS-17053 (N-[2-(2-cyclopropylmethoxyphenoxy)ethyl]-5-chloro-alpha, alpha-dimethyl-1H-indole-3-ethanamine hydrochloride), a selective alpha 1A-adrenoceptor antagonist, displays low affinity for functional alpha 1-adrenoceptors in human prostate: implications for adrenoceptor classification
14. Receptor binding profile of cyclazosin, a new alpha1B-adrenoceptor antagonist
15. Characterization of alpha-1 adrenoceptor subtypes in human and canine prostate membranes
16. Noradrenergic modulation of midbrain dopamine cell firing elicited by stimulation of the locus coeruleus in the rat
17. 1-Adrenoceptor subtypes: a synopsis of their pharmacology and molecular biology
18. Measurement of 3-methoxy-4-hydroxyphenylglucol (MHPG) in mouse brain by h.p.l.c. with electrochemical detection, as an index of noradernaline utilisation and presynaptic α2-adrenoceptor function
19. 1-adrenoceptor mediating contractions of rat vas deferens
20. Pharmacological properties of the cloned alpha 1A/D-adrenoceptor subtype are consistent with the alpha 1A-adrenoceptor characterized in rat cerebral cortex and vas deferens
21. 1 -adrenoceptors in the rat CNS. In vitro binding and autoradiographic studies
22. Effects of locus coeruleus lesions on the release of endogenous dopamine in the rat nucleus accumbens and caudate nucleus as determined by intracerebral microdialysis
23. Differential modulation of (+)-amphetamine-induced rotation in unilateral substantia nigra-lesioned rats by α1 as compared to α2 agonists and antagonists
24. 1-adrenoceptor subtypes
25. Interaction of subtype selective antagonists with alpha 1-adrenergic receptor mediated second messenger responses in the rat brain
26. Further characterization of the alpha-1 receptor subtype involved in the control of cataplexy in canine narcolepsy
27. Pharmacological differentiation and characterization of 5-HT1A, 5HT1B, 5HT1C binding sites in rat frontal cortex
28. Possible function of alpha-1 adrenoceptors in the CNS in anesthetized and conscious animals
29. 1 adrenoceptors in rat brain revealed by in situ hybridization experiments utilizing subtype-specific probes
30. Circling behaviour produced by unilateral lesions in the region of the locus coeruleus in rats
31. The catecholamine hypothesis of affective disorders: A review of the supporting evidence
32. Cloning and pharmacological characterization of human alpha-1 adrenergic receptors: Sequence corrections and direct comparison with other species homologues
33. Non-amphetaminic mechanism of stimulant locomotor effect of modafinil in mice
34. Noradrenergic involvement in the discriminative stimulus effects of cocaine in squirrel monkeys
35. Stereoselective discrimination of serotoninergic 5HT-1A and 5HT-1B binding sites using enantiomers of spiroxatrine and WB-4101
36. Effect of stress on norepinephrine-stimulated accumulation of cyclic AMP in rat brain slices
37. Regulation of alpha and beta components of noradrenergic cyclic AMP response in cortical slices
38. The effect of repeated restraint stress, desmethylimipramine or adrenocorticotropin on the alpha and beta adrenergic components of the cyclic AMP response to norepinephrine in rat brain slices
39. Brain alpha 1-adrenergic neurotransmission is necessary for behavioral activation to environmental change in mice
40. The alpha 1d-adrenoceptor subtype is involved in the noradrenaline- induced contractions of rat aorta
41. Standard binding and functional assays related to medications development division for testing for potential cocaine and opiate narcotic treatment
42. 1-adrenoceptor subtypes in facilitation of rat spinal motoneuron activity
43. Locus coeruleus neurons: Cessation of activity during cataplexy
44. 1-adrenoceptor subtypes. I
45. The involvement of central noradrenergic systems and corticotropin-releasing factor in defensive-withdrawal in rats
46. BMY 7378, a buspirone analog with high affinity selectivity and low intrinsic activity at the 5HT1A receptor in rat and guinea pig hippocampal membranes